Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This behavioral clinical trial evaluates an adaptively tailored, mobile phone-delivered intervention (MOSAIC) designed to support adults managing their type 2 diabetes. Adaptive means the intervention can change over time. Tailored means the intervention may be different for different participants. The main questions the study will aim to answer are:
Participants will enroll in a 16-month study with assessments every 4 months. Assessments include completion of an A1c test and a survey. For those assigned to MOSAIC, they will experience 12-months of mobile phone-delivered support with 3 opportunities for intervention tailoring.
Full description
MOSAIC intervention components include:
PWD participants will be randomized in a parallel design to the MOSAIC adaptive mobile phone-delivered intervention or to print materials alone. The study is powered to detect a 0.5% reduction in hemoglobin A1c. Analyses will examine effects during the intervention (4 and 8 months) and post-intervention (12 months) and sustained effects (16 months). Participants will be analyzed as randomized regardless of withdrawal from the intervention (i.e., intention-to-treat principals) and missing data will be imputed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
PERSONS WITH DIABETES:
SUPPORT PERSONS:
Exclusion criteria
PERSONS WITH DIABETES:
SUPPORT PERSONS:
Primary purpose
Allocation
Interventional model
Masking
547 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Lindsay S Mayberry, PhD, MS; Erin M Bergner, PhD, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal